-
first-in-human Phase 1 multi-centre trial of melatonin in this population, the aim is to evaluate the safety and pharmacokinetics of IV melatonin in term neonates with HIE receiving therapeutic
-
encephalopathy (HIE) undergoing therapeutic hypothermia (HT) treatment. As this is the first-in-human Phase 1 multi-centre trial of melatonin in this population, the aim is to evaluate the safety and
-
not apply and should refer to PD2 posts instead. Prior to application, further information (including application procedure) should be obtained from the Work at UCD website: https://www.ucd.ie/workatucd
Enter an email to receive alerts for information-security-"https:" positions